EGFR and colorectal carcinoma: First, expression of phosphorylated EGFR in models found to be refractory to MEDI3622 treatment (CRC 14-136 and GB-CO-23) showed similar pEGFR expression levels to the responsive CRC 13-1333 model (Supplementary Figure 3).